Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan vs atenolol for prevention of progressive aortic dilatation in Marfan syndrome
2007-001125-97Phase 3Active
- Sponsor
- Alberto Forteza
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of losartan and atenolol in Marfan syndrome (MFS) (2 arms), sponsored by Alberto Forteza. Primary endpoint: Progression of aortic dilatation. Started Dec 2007; status: active.
02
Drugs
losartanatenolol
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on 2007-001125-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001125-97.